Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, LIC, SCZ

Reemo Health and HNC Virtual Solutions Announce Transformative Connected Health Solution for Healthy Aging


MINNEAPOLIS, Oct. 16, 2018 /PRNewswire/ -- Reemo Health, the personalized enablement platform that protects the independence of the young at heart, and HNC Virtual Solutions, a fast-paced, highly-focused telemedicine development company, are announcing today a reimagined solution for the 65+ demographic to effectively and proactively manage health and independence. The new offering combines longitudinal insights, continuous consumer access, and condition monitoring into one unified platform and consumer experience. The innovative program enables payers and providers to engage consumers in their health, while also better managing risk and identifying preemptive insights, through a closed-loop, scalable experience.

Reemo Health Logo

The joint Reemo and HNC Virtual Solutions program is for Medicare, Medicaid, health systems and life science organizations concerned with better engaging their 65+ demographic in their health. As this population segment rapidly grows, the need to provide more efficient and enhanced care in a personalized manner is critical to stemming increased health risks and their associated costs. Reemo and HNC Virtual Solutions strive to be the change agent leading this charge.

"Reemo delivers a true 1:1 relationship with any consumer facing the challenge of remaining healthy, active and safe as they age. Their wealth of insights and ability to engage the consumer in their care circle unlocks a potential to deliver the most appropriate care at the lowest acuity level that was previously unattainable at scale," said Stephen Shaya, M.D., Chief Medical Officer of HNC. "This is precisely why HNC Virtual Solutions is confident that our combined offering will redefine what it means to provide remote care and on-demand support across the full continuum of risk. This is a life-changing opportunity for millions of people."

The solution is purpose-built for the 65+ demographic to effectively and proactively manage health and independence, and is comprised of four core principles:

"HNC's proven innovation and commitment to solving the needs of all the stakeholders responsible for the health and care of the aging demographic is a mission I greatly admire and recognize is not easy," states John Valiton, CEO of Reemo Health. "Together, I truly believe Reemo and HNC are uniquely positioned to positively impact millions of seniors and their adult caregivers as they partner with their healthcare organizations to remain independent and live their life to the fullest."

The solution will be available January 2019. For more information on availability contact [email protected].

About Reemo Health
Reemo helps healthcare organizations improve the healthy aging experience by empowering the 65+ demographic to be supported, be connected and be independent. Blending wearable technology, next-gen PERS functionality and advanced health analytics into a connected-caregiving solution, Reemo delivers the industry's first unified personal enablement platform across the full continuum of independence. For more information on how Reemo protects personal independence, visit Reemohealth.com or follow the company on LinkedIn and Twitter.

About HNC Virtual Solutions
HNC Virtual Solutions is a fast-paced, highly-focused telemedicine development company located in Wixom, MI. HNC is composed of skilled system engineers, programmers, project specialists, and organizational managers, whose primary focus is to continue to design and implement Telemedicine and Remote Patient Monitoring solutions that are second to none. As a proud member of the J&B Medical Supply family of companies, HNC KNOWS technology AND Medicine. To learn more about HNC Virtual Solutions, please visit HNCVirtualSolutions.com.

 

SOURCE Reemo Health


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: